(NASDAQ: EMBC) Embecta's forecast annual revenue growth rate of 2.55% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 9.19%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.72%.
Embecta's revenue in 2026 is $1,042,500,000.On average, 6 Wall Street analysts forecast EMBC's revenue for 2026 to be $61,819,439,434, with the lowest EMBC revenue forecast at $59,019,173,080, and the highest EMBC revenue forecast at $63,836,580,452. On average, 6 Wall Street analysts forecast EMBC's revenue for 2027 to be $65,557,083,085, with the lowest EMBC revenue forecast at $62,768,682,266, and the highest EMBC revenue forecast at $67,633,551,780.
In 2028, EMBC is forecast to generate $66,091,032,178 in revenue, with the lowest revenue forecast at $63,065,320,651 and the highest revenue forecast at $68,642,122,289.